Gsk Consumer Healthcare

Gsk Consumer Healthcare GSK has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business, according to reports In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price

Gsk Consumer Healthcare Updates Global Roster With Nine Agencies In British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of BENSALEM, PA — Healthcare Services Group, Inc (NASDAQ: HCSG) has announced significant leadership changes, appointing Vikas Singh as Executive Vice President and Chief Financial Officer, effective The $13 billion acquisition of Change Healthcare strengthens GSK as a prime candidate for investment Diversified product portfolio across pharmaceuticals, vaccines and consumer health care British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage

Gsk Consumer Healthcare Unites 900 Employees In New 109 000 Square Foot The $13 billion acquisition of Change Healthcare strengthens GSK as a prime candidate for investment Diversified product portfolio across pharmaceuticals, vaccines and consumer health care British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline GSK could beat Pfizer to market, says chief commercial officer Several drugmakers are betting on mRNA seasonal flu vaccines Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on GSK PLC, a major player in the,Healthcare sector,, has reported positive initial results from its seasonal flu vaccine using mRNA technology The FTSE 100 company announced that the phase II trial of Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet

Nova Gsk Consumer Healthcare Inicia Operaг гµes No Brasil Revista Analytica GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline GSK could beat Pfizer to market, says chief commercial officer Several drugmakers are betting on mRNA seasonal flu vaccines Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on GSK PLC, a major player in the,Healthcare sector,, has reported positive initial results from its seasonal flu vaccine using mRNA technology The FTSE 100 company announced that the phase II trial of Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet GSK Plc’s experimental drug helped prevent serious asthma attacks in two late-stage studies, easing the path forward for a medicine that the British company says could reach £3 billion ($39 Consumer staples are essential goods like food The Motley Fool recommends GSK, Philip Morris International, and Unilever The Motley Fool has a disclosure policy Calculated by average return